Arvinas

Developer of small molecule drugs to target and degrade disease causing proteins

placeNew Haven, Connecticut, United States calendar_todayFounded 2013 groups266 employees language arvinas.com

Registered entities

Social engagement

Social engagement: 31K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

16 investors on record; lead investors include Nextech Invest, Canaan, 5AM Ventures, RA Capital Management.

Investor typeCountShare
Venture capital1063%
Private equity425%
Bank & private debt16%
Other / undisclosed16%

Hiring activity

Hires periodically

5 roles tracked across 4 of the last 12 months

8 Feb 2026 · Summer Intern Neuroscience · New Haven

18 Jan 2026 · Associate Director, Clinical Development & Medical Affairs (CDMA) Operations & Innovation · New Haven

12 Jan 2026 · Co-op Biology-Oncology · New Haven

3 Nov 2025 · Manager, Accounting Operations · New Haven

Based on job postings tracked across public sources.

Recent activity

4 Jun 2026
Partnership
The Michael J. Fox Foundation for Parkinson's Research LITE and PPMI programs
1 Jun 2026
Event
American Society of Clinical Oncology (ASCO) annual meeting
Coming soon